JERSEY CITY, N.J. , June 15, 2022 /PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of market assessment report on "Global Cell Therapy Packaging Products and Services Market (Therapy (T-cell Therapies, Dendritic Cell Vaccines, Stem Cell Therapies, NK Cell Therapies, and Other ATMPs), Package Engineering Design (Primary Packaging and Secondary Packaging), Scale of Operation (Clinical and Commercial))– By Trends, Industry Competition Analysis, Revenue and Forecast Till 2030"
According to the latest research by InsightAce Analytic, the global cell therapy packaging products and services market is expected to reach US$ 1,252.14 Million in 2030, recording a promising CAGR of 20.32% during the period of 2022-2030.
Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1265
Cell therapy aims to modify genetic material to treat different chronic diseases. Cell and gene therapy is the most significant medical advance in recent history. The increasing investments by key players in the development of promising therapies and advanced packaging technologies are anticipated to fuel the market growth over the forecast period.
Biopharmaceutical companies are investing in developing and manufacturing new customizable "patient-centered medicine" and modernizing their supply chains. Although biopharmaceutical firms' primary focus is on the drug product (DP) research and production and delivery methods (e.g., syringes), packaging and labelling are crucial to ensuring product quality and efficacy. The packaging of cell and gene therapy products must maintain closure integrity and product stability and allow simple access to the product while remaining functional during heat and mechanical loads experienced. The packaging must be designed to endure cryogenic temperatures without compromising the quality of the biological material or its longevity. For instance, In February 2022 , Sharp, a leading provider in contract packaging and clinical supply services, has designed new purpose-built production suites to fulfil the rising demand from producers of gene treatments for dedicated and specialized packaging capacity. The innovative secondary packaging by Sharp aims to give an appropriate environment for tackling the challenges of gene treatments, notably at low temperatures and distribution in cold and ultra-cold supply chains. In summary, packaging technology and engineering, graphics, and labelling design are vital components of the development and marketing of gene and cell therapy programs.
Major driving factors of the cell therapy packaging products and services market are the increasing need for cell therapies, advancements in packaging and labelling, high prevalence of cancer diseases. Furthermore, advanced medical technologies, the rising trend of outsourcing in the healthcare industry, and the ongoing efforts of service providers to further improve their portfolios are enhancing the growth of the cell therapy packaging products and services market. However, the high cost of manufacturing systems, lack of standard therapy protocols, and complex procedures are restraining the growth of this market.
Geographically, the North America region is the primary revenue holder of this market due to rising awareness about cell and gene therapies, increasing government investments in the research and development of cell therapies, stringent regulations and an increasing number of human chronic diseases. On the other hand, Europe will also dominate the market during the forecast period due to advancements in the biopharmaceutical field and stringent regulations. The Asia-Pacific market is expected to grow faster in the future due to the growing cell therapy manufacturing industries and the adoption of new technologies.
Major key players in the cell therapy packaging products and services market are Almac, Catalent Pharma Solutions, Cryoport Systems, Core Cryolab Inc., Yourway, Lufthansa Cargo, Saint-Gobain Life Sciences, Thermo Fisher Scientific, Sharp, West Pharmaceutical Services, Chart Industries Inc., and Other Prominent Players. Leading manufacturers in this field focus on novel therapy innovations, partnerships, collaborations, mergers, and agreements. These strategies will help to boost their growth opportunities in this market.
In Feb 2022 , Cell and gene therapy developers may now access Thermo Fisher Scientific's new integrated commercial packaging and distribution capabilities, which are designed to facilitate a seamless transition from the clinic to commercial launch for patients in the United States and Europe . Patheon Commercial Packaging Services for Cell and Gene Therapies (CGT) is an end-to-end solution that combines GMP storage, serialisation, ultracold and cryogenic packaging, and worldwide distribution to support the logistical strategies of developers.
In February 2020 , Almac and Pfizer revealed steps to slash gene therapy labelling times. In April 2018 , Almac Group, the global contract pharmaceutical development and manufacturing organization, expanded its US commercial packaging capabilities at its Audubon, PA facility.
In October 2020 , Thermo Fisher Scientific announced the launch of its Gibco CTS Rotea Counterflow Centrifugation System, a modular, closed-cell therapy processing system that enables scalable, cost-effective cell therapy development and manufacturing. The CTS Rotea system is the first Gibco instrument for cell therapy processing applications and facilitates workflows from research through GMP clinical development and commercial manufacturing.
Curious about this latest version of report? Enquire Before Buying @ https://www.insightaceanalytic.com/enquiry-before-buying/1265
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 based on Therapy
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 based on Package Engineering Design
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 based on Scale of Operation
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 based on Region
North America cell therapy packaging products and services market revenue (US$ Million) by Country, 2022 to 2030
Europe cell therapy packaging products and services market revenue (US$ Million) by Country, 2022 to 2030
Asia Pacific cell therapy packaging products and services market revenue (US$ Million) by Country, 2022 to 2030
Latin America cell therapy packaging products and services market revenue (US$ Million) by Country, 2022 to 2030
Middle East & Africa cell therapy packaging products and services market revenue (US$ Million) by Country, 2022 to 2030
Rest of Middle East & Africa
For Customized Information @ https://www.insightaceanalytic.com/customisation/1265
Other Related Reports Published by InsightAce Analytic:
Global Cell and Gene Therapy Bioassay Services Market
Global Vaccine Cold Chain Logistics Market
Global Cell and Gene Therapy Drug Delivery Devices Market
Why should buy this report:
To receive a comprehensive analysis of the prospects for global cell therapy packaging products and services market
To receive industry overview and future trends of global cell therapy packaging products and services market
To analyse the cell therapy packaging products and services market drivers and challenges
To get information about the cell therapy packaging products and services market size value (US$ Mn) forecast till 2030
Major Investments, Mergers & Acquisition in global cell therapy packaging products and services market industry
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
InsightAce Analytic Pvt. Ltd. Tel.: +1 718 593 4405 Email: info@insightaceanalytic.com Site Visit: www.insightaceanalytic.com Follow Us on LinkedIn @ bit.ly/2tBXsgS Follow Us On Facebook @ bit.ly/2H9jnDZ
Logo: https://mma.prnewswire.com/media/1729637/InsightAce_Analytic_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/cell-therapy-packaging-products-and-services-market-worth-1-25-billion-by-2030---exclusive-report-by-insightace-analytic-301568387.html
SOURCE InsightAce Analytic Pvt. Ltd.
In this piece we will take a look at the nine shipping stocks that pay dividends. If you want to skip our primer on the shipping industry, the attractiveness of dividends, and want to take a look at the top five stocks in this piece, then head on over to 5 Best Shipping Stocks That […]
In this article, we discuss the 10 best beginner stocks to invest in right now. If you want to skip our detailed commentary on which stocks are best for beginners and why, go directly to 5 Best Beginner Stocks To Invest In Right Now. Smartphone applications like Robinhood Markets, Inc. (NASDAQ:HOOD) which enable users to […]
Zoom Video Communications was a big winner during the early part of the covid pandemic. Shares of the video conferencing company shot higher through 2020 as office workers hunkered down at home and started holding all their meetings online. In fact, her open-source research shop came out recently with some eye-popping expectations for Zoom over the next four years.
Sterling slumped to its lowest level against the dollar since the pandemic as Nicola Sturgeon’s renewed independence threats compounded recession fears.
(Bloomberg) -- Activists are back and UK Plc is their main target in Europe.Most Read from BloombergChina Alarms US With Private Warnings to Avoid Taiwan StraitStocks’ Pandemic Bull Run Ends With Recession Fear: Markets WrapCrypto Market Sinks Below $1 Trillion After Latest DeFi BlowupBond Yields, Dollar Surge With Fed Bets as Recession Risk GrowsBitcoin Turns Lower Again as Celsius Weighs on SentimentHaving given CEOs a pass in the depths of the Covid-19 pandemic, activist investors big and sma
(Bloomberg) -- The latest jumps in consumer prices and inflation expectations will probably spur Federal Reserve officials to consider the biggest interest-rate increase since 1994 when they meet this week, after Chair Jerome Powell previously signaled a smaller move was the likely outcome.Most Read from BloombergChina Alarms US With Private Warnings to Avoid Taiwan StraitStocks’ Pandemic Bull Run Ends With Recession Fear: Markets WrapCrypto Market Sinks Below $1 Trillion After Latest DeFi Blowu
As inflation sits at a 40-year high, you may be asking yourself if you actually have too much money in your traditional savings account. With that in mind, it may seem counterintuitive to keep an emergency stash of liquid cash within arm’s reach, but Lauren Anastasio, director of financial advice at Stash, the online financial platform, says inflation is your cash’s greatest enemy — but cash is still king in the short-term. “Maintaining a cash cushion for emergencies is always encouraged, and you should also have any large upcoming expenses accounted for in cash,” says Anastasio.
Binance US gets hit with a lawsuit today, with US investors claiming that the exchange illegally sold UST and LUNA to add further BNB price pressure.
BYD stock is racing toward highs as the China EV giant seizes Tesla's sales crown. Now it's going to supply Tesla with batteries.
Nonprofit that urges disclosure of corporate political activity is stepping up its efforts to track election-related spending, after a prod from big money managers.
“Today’s layoff is the result of shortfalls in Redfin’s revenues…With May demand 17% below expectations, we don’t have enough work,” said Redfin in a statement.
(Bloomberg) -- China’s central bank abstained from cutting a key policy interest rate, avoiding further policy divergence from the US that could add pressure on the yuan. Most Read from BloombergAmericans Are Building Vacation-Home Empires With Easy-Money LoansChina Alarms US With Private Warnings to Avoid Taiwan StraitVolatility Grips Stocks as Treasury Yields Surge: Markets WrapBiden’s ‘Never Been More Optimistic’ Despite Troubled US EconomyStocks’ Pandemic Bull Run Ends With Recession Fear: M
HQY stock rebounded from it 50-day line into a buy range. But it remains a hands-off play until the market's manners improve.
MicroStrategy the business-intelligence software maker that borrowed money to invest in as an inflation hedge, is facing a growing threat of a margin call as the cryptocurrency’s value continues to fall. Shares of MicroStrategy (ticker: MSTR) plummeted more than 25% on Monday and fell 0.6% in premarket trading Tuesday. The company owns more than 129,200 Bitcoin tokens and said it would face a margin call—a demand from creditors for a bigger deposit to cover possible losses—if the cryptocurrency slips below $21,000.
Bitcoin slumped to about $23,000, as the Celsius withdrawal halt combined with a sell-off in traditional markets to sour trader spirits.
(Bloomberg) -- Glencore Plc is getting rich on coal. The company is on course for another year of bumper profits, its shares just hit a record high — a feat that looked unlikely for most of the last decade — and investors are set for a windfall of returns.Most Read from BloombergChina Alarms US With Private Warnings to Avoid Taiwan StraitStocks’ Pandemic Bull Run Ends With Recession Fear: Markets WrapCrypto Market Sinks Below $1 Trillion After Latest DeFi BlowupBond Yields, Dollar Surge With Fed
Nashville International Airport's Hudson Nonstop concession shop is the latest location to add Amazon.com Inc. "Just Walk Out" technology, which allows customers to bypass checkout when purchasing items. Shoppers swipe a credit card or wave their palm above an Amazon One device when they enter, and leave with their items when they're done shopping. Amazon One links a shopper's palm to a payment method. Just Walk Out is also available in Houston's Minute Maid Park, at New York's LaGuardia Airport
(Bloomberg) -- French oil giant TotalEnergies SE and Indian billionaire Gautam Adani’s conglomerate are partnering to fund billions of dollars worth of green hydrogen development in India as the world’s third-largest polluter seeks to decarbonize.Most Read from BloombergChina Alarms US With Private Warnings to Avoid Taiwan StraitVolatility Grips Stocks as Treasury Yields Surge: Markets WrapAmericans Are Building Vacation-Home Empires With Easy-Money LoansBiden’s ‘Never Been More Optimistic’ Desp
Companies raised about $87 billion in investment-grade debt for all of May, the lowest monthly amount since 2012.
Both companies are major players in the Puget Sound region, where the industrial market is supercharged.